If you need more lookups,
subscriptions start at $34 USD/month.
David Strochlic Location
Cambridge, MA, US
David Strochlic Work
Senior Director, Biology @ (March 2026 - Present)
Director, Discovery Biology @ (June 2024 - March 2026)
Associate Director, Discovery Biology @ (December 2021 - May 2024)
Associate Director @ Cygnal Therapeutics (July 2021 - December 2021)
Senior Scientist @ Cygnal Therapeutics (March 2020 - July 2021)
Scientist II - Ophthalmology Research @ (June 2018 - February 2020)
Scientist I - Neurology Research @ (December 2015 - June 2018)
Postdoctoral Fellow @ (June 2015 - November 2015)
Doctoral Research @ (September 2008 - May 2015)
Research Technician @ (November 2006 - July 2008)
Undergraduate Honors Research @ (May 2003 - October 2006)
David Strochlic Education
Harvard University
Doctor of Philosophy (PhD) (Neuroscience)
2008-2015
Tufts University
BS (Biology)
2002-2006
Duke University
Organization for Tropical Studies: Costa Rica
2005-2005
David Strochlic Skills
PCR
Gel Electrophoresis
Customer Service
Molecular Biology
DNA sequencing
Tissue Culture
Animal Models
Mouse Models
Neuroscience
Sds Page
in Situ Hybridization
Physiology
Fluorescence Microscopy
Immunohistochemistry
Data Analysis
Molecular Cloning
Western Blotting
Biochemistry
Cell Culture
Cell Biology
Project Management
qPCR
Microscopy
Molecular Genetics
Genetics
In Vivo
In Vitro
Confocal Microscopy
Lifesciences
David Strochlic Summary
David Strochlic, based in Cambridge, MA, US, is currently a Senior Director, Biology at Soufflé Therapeutics. David Strochlic brings experience from previous roles at Soufflé Therapeutics, VC-Backed Biotech NewCo and Cygnal Therapeutics. David Strochlic holds a 2008 - 2015 Doctor of Philosophy (PhD) in Neuroscience @ Harvard University. With a robust skill set that includes PCR, Gel Electrophoresis, Customer Service, Molecular Biology, DNA sequencing and more. David Strochlic has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different David Strochlic?
Find contact details for 700 million professionals.